Biocept Inc

NASDAQ:BIOC   3:59:54 PM EDT
4.00
+0.08 (+2.04%)
Earnings Announcements

Biocept Reports Second Quarter 2021 Financial Results

Published: 08/16/2021 20:52 GMT
Biocept Inc (BIOC) - Biocept Reports Second Quarter 2021 Financial Results.
Biocept Inc - Q2 Revenues of $12.0 Million Driven by Rt-pcr Covid-19 Testing.
Biocept Inc Qtrly Loss per Share $0.14.
Biocept Inc - Reported Cash and Cash Equivalents As of June 30, 2021 of $19.5 Million.
Revenue is expected to be $15.24 Million
Adjusted EPS is expected to be $0.04

Next Quarter Revenue Guidance is expected to be $12.76 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.